BEAM:BMV
Beam Therapeutics Inc
MX$439.00
arrow_downward
-0.63%(-2.79) 1D
Oct 2, 2:00:00 PM GMT-6 · MXN
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for BEAM...
Open
MX$439.00
High
MX$439.00
Low
MX$439.00
Mkt. cap
2.53B
Avg. vol.
12.00
Volume
49.00
52-wk high
MX$663.44
52-wk low
MX$384.79
No. of employees
540
Open
MX$439.00
High
MX$439.00
Low
MX$439.00
Mkt. cap
2.53B
Avg. vol.
12.00
Volume
49.00
52-wk high
MX$663.44
52-wk low
MX$384.79
No. of employees
540
News stories
From web sources and news partners
FXLeaders
·
18 minutes ago
Dow Jones and Nasdaq Futures Open Higher as Buyers Target New Records
InteractiveCrypto
·
10 hours ago
The S&P 500 Looks Strong. Underneath, October Looks Thin.
Traders Union
·
4 hours ago
S&P500 has posted gains in nearly every November-through-June period since 1942, Lia Holmgren notes
Forbes
·
11 hours ago
S&P 500 Q3 Earnings Preview: Trends Investors Need To Watch
Profile
Beam Therapeutics Inc. is an American biotechnology company conducting research in the field of gene therapies and genome editing. The company is headquartered in Cambridge, Massachusetts. In the development of therapies, the company relies on CRISPR base editing and prime editing, whereby single nucleotides in a DNA sequence can be enzymatically modified without producing double-strand breaks. Wikipedia
About Beam Therapeutics Inc